Pyry I. Toivanen

591 total citations
17 papers, 477 citations indexed

About

Pyry I. Toivanen is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Pyry I. Toivanen has authored 17 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Surgery. Recurrent topics in Pyry I. Toivanen's work include Angiogenesis and VEGF in Cancer (11 papers), Lymphatic System and Diseases (6 papers) and Axon Guidance and Neuronal Signaling (4 papers). Pyry I. Toivanen is often cited by papers focused on Angiogenesis and VEGF in Cancer (11 papers), Lymphatic System and Diseases (6 papers) and Axon Guidance and Neuronal Signaling (4 papers). Pyry I. Toivanen collaborates with scholars based in Finland, Sweden and Netherlands. Pyry I. Toivanen's co-authors include Seppo Ylä‐Herttuala, Tommi Heikura, Kari Alitalo, Suvi Jauhiainen, Johanna P. Laakkonen, Minna U. Kaikkonen, Kari J. Airenne, Denis Tvorogov, Antti Saraste and Veli‐Matti Leppänen and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Blood.

In The Last Decade

Pyry I. Toivanen

17 papers receiving 471 citations

Peers

Pyry I. Toivanen

ONCOL

SURGE

CCM

GENET

Eleanor Hilliard United States

Shuichiro Higo Japan

Peter J. Noy United Kingdom

Françoise Pujol France

Cristina Villa del Campo Spain

Jingchun Yang United States

Jeffrey L. Feldman United States

Daniel O. Kechele United States

Mahdi Noureddini Iran

Rajat M. Gupta United States

Eleanor Hilliard United States

Pyry I. Toivanen

356 ×1.2

106 ×0.9

ONCOL

88 ×1.0

SURGE

114 ×1.5

CCM

39 ×0.7

GENET

Citations per year, relative to Pyry I. Toivanen Pyry I. Toivanen (= 1×) peers Eleanor Hilliard

Countries citing papers authored by Pyry I. Toivanen

Since Specialization

Citations

This map shows the geographic impact of Pyry I. Toivanen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pyry I. Toivanen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pyry I. Toivanen more than expected).

Fields of papers citing papers by Pyry I. Toivanen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pyry I. Toivanen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pyry I. Toivanen. The network helps show where Pyry I. Toivanen may publish in the future.

Co-authorship network of co-authors of Pyry I. Toivanen

This figure shows the co-authorship network connecting the top 25 collaborators of Pyry I. Toivanen. A scholar is included among the top collaborators of Pyry I. Toivanen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pyry I. Toivanen. Pyry I. Toivanen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Puranen, Jooseppi, et al.. (2022). Antiangiogenic AAV2 gene therapy with a truncated form of soluble VEGFR-2 reduces the growth of choroidal neovascularization in mice after intravitreal injection. Experimental Eye Research. 224. 109237–109237. 8 indexed citations

Mallick, Rahul, et al.. (2022). Novel Designed Proteolytically Resistant VEGF-B186R127S Promotes Angiogenesis in Mouse Heart by Recruiting Endothelial Progenitor Cells. Frontiers in Bioengineering and Biotechnology. 10. 907538–907538. 5 indexed citations

Korpela, H, Rahul Mallick, Pyry I. Toivanen, et al.. (2021). Adenoviral VEGF-B186R127S gene transfer induces angiogenesis and improves perfusion in ischemic heart. iScience. 24(12). 103533–103533. 6 indexed citations

Jauhiainen, Suvi, Johanna P. Laakkonen, Kirsi Ketola, et al.. (2019). Axon Guidance-Related Factor FLRT3 Regulates VEGF-Signaling and Endothelial Cell Function. Frontiers in Physiology. 10. 224–224. 19 indexed citations

Toivanen, Pyry I., et al.. (2017). Snake venom VEGF Vammin induces a highly efficient angiogenic response in skeletal muscle via VEGFR-2/NRP specific signaling. Scientific Reports. 7(1). 5525–5525. 10 indexed citations

Hartikainen, Juha, Antti Hedman, Antti Kivelä, et al.. (2017). Adenoviral intramyocardial VEGF-DΔNΔC gene transfer increases myocardial perfusion reserve in refractory angina patients: a phase I/IIa study with 1-year follow-up. European Heart Journal. 38(33). 2547–2555. 111 indexed citations

Laakkonen, Johanna P., Jari P. Lappalainen, Thomas Theelen, et al.. (2016). Differential regulation of angiogenic cellular processes and claudin-5 by histamine and VEGF via PI3K-signaling, transcription factor SNAI2 and interleukin-8. Angiogenesis. 20(1). 109–124. 31 indexed citations

Toivanen, Pyry I., Johanna P. Laakkonen, Tommi Heikura, et al.. (2015). Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle via reduced eNOS activity. Cardiovascular Research. 107(2). 267–276. 13 indexed citations

Hartikainen, Juha, Antti Hedman, Antti Kivelä, et al.. (2015). Abstract 11987: Adenoviral Intramyocardial VEGF-D Gene Transfer Increases Myocardial Perfusion in Refractory Angina Patients. Circulation. 132(suppl_3). 6 indexed citations

10.

Sallinen, Hanna, J. Koponen, Maarit Anttila, et al.. (2013). Preclinical Safety, Toxicology, and Biodistribution Study of Adenoviral Gene Therapy with sVEGFR-2 and sVEGFR-3 Combined with Chemotherapy for Ovarian Cancer. PubMed. 24(1). 29–37. 9 indexed citations

11.

Toivanen, Pyry I., Tommi Heikura, Suvi Jauhiainen, et al.. (2013). The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features. Biochimica et Biophysica Acta (BBA) - General Subjects. 1840(1). 454–463. 26 indexed citations

12.

Kontturi, Leena-Stiina, Marjo Yliperttula, Pyry I. Toivanen, et al.. (2011). A laboratory-scale device for the straightforward production of uniform, small sized cell microcapsules with long-term cell viability. Journal of Controlled Release. 152(3). 376–381. 30 indexed citations

13.

Jauhiainen, Suvi, Sanna-Kaisa Häkkinen, Pyry I. Toivanen, et al.. (2011). Vascular Endothelial Growth Factor (VEGF)-D Stimulates VEGF-A, Stanniocalcin-1, and Neuropilin-2 and Has Potent Angiogenic Effects. Arteriosclerosis Thrombosis and Vascular Biology. 31(7). 1617–1624. 35 indexed citations

14.

Leppänen, Veli‐Matti, Michael Jeltsch, Andrey Anisimov, et al.. (2010). Structural determinants of vascular endothelial growth factor-D receptor binding and specificity. Blood. 117(5). 1507–1515. 75 indexed citations

15.

Lesch, Hanna P., Antti Määttä, Pyry I. Toivanen, et al.. (2009). A 96-well format for a high-throughput baculovirus generation, fast titering and recombinant protein production in insect and mammalian cells. BMC Research Notes. 2(1). 63–63. 23 indexed citations

16.

Toivanen, Pyry I., Annamari Alitalo, Suvi Jauhiainen, et al.. (2009). Novel Vascular Endothelial Growth Factor D Variants with Increased Biological Activity. Journal of Biological Chemistry. 284(23). 16037–16048. 28 indexed citations

17.

Sallinen, Hanna, Maarit Anttila, Johanna Närväinen, et al.. (2008). Antiangiogenic Gene Therapy With Soluble VEGFR-1, -2, and -3 Reduces the Growth of Solid Human Ovarian Carcinoma in Mice. Molecular Therapy. 17(2). 278–284. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact